Skip to content

Flexion Therapeutics, Inc.

CIK 0001419600

← back to feed
Revenue (TTM)
$97.75M
+11.2% YoY Q3 Nov 2021
Net Income (TTM)
−$105.71M
+20.3% YoY Q3 Nov 2021
EPS Diluted (TTM)
—
Q3 Nov 2021
Gross Margin
20.4%
Q3 Nov 2021
Operating Margin
-85.0%
Q3 Nov 2021
Net Margin
-108.1%
Q3 Nov 2021
Free Cash Flow (TTM)
−$135.08M
Q3 Nov 2021
Cash
$136.82M
Q3 Nov 2021
Total Debt
$80.09M
Q3 Nov 2021
Shares Outstanding
50.32M sh
Q3 Nov 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings